One study is a multinational adjuvant ( post - operative ) clinical trial evaluating disease - free and overall survival in women with breast cancer who take femara after having remained disease - free with five years of tamoxifen therapy 一项研究是多国辅药（术后）临床试验，用以评估乳癌患者服用弗隆后的无瘤生存率和整体生存率，这些女患者之前已进行了5年的他莫昔芬治疗，一直未发病。
